(Q34729086)

4 August 2017

1 reference

title

Counseling the at risk patient in the BRCA1 and BRCA2 Era. (English)

1 reference

4 August 2017

Inbal M Barnes-Kedar

1

1 reference

4 August 2017

Sharon E Plon

series ordinal

2

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Obstetrics and Gynecology Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

29

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

341-66, vii

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Women's receptivity to testing for a genetic susceptibility to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

BRCA1, BRCA2, and DNA damage response: collision or collusion?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Cancer risks in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Mutation analysis in the BRCA2 gene in primary breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Low penetrance genes associated with increased risk for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

A genetic epidemiological study of carcinoma of the fallopian tube

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Breast cancer genetics: what we know and what we need

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Multiple primary cancers in families with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

An update on Lynch syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Effects of individualized breast cancer risk counseling: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Psychologic aspects of cancer genetic testing: a research update for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

A descriptive study of BRCA1 testing and reactions to disclosure of test results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

"Other" breast cancer susceptibility genes: searching for more holy grail

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Clinical options for women at high risk for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

The role of ultrasound in the diagnosis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

MR imaging of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Magnetic resonance imaging of breast cancer: clinical indications and breast MRI reporting system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

First experiences in screening women at high risk for breast cancer with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Tamoxifen, raloxifene, and the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

Psychological responses to BRCA1 mutation testing: preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2801%2900004-3

7 January 2021

10.1016/S0889-8545(01)00004-3

Identifiers

DOI

1 reference

4 August 2017

1 reference